4-(3,5-Dioxo-10-oxa-4-azatricyclo-[5.2.1.0 2,6]decan-4-yl)-10- oxa-4-azatricyclo-[5.2.1.0 2,6]decane-3,5-dione

Pengpeng Wang,Qiuyue Lin,Fan Zhang

DOI: https://doi.org/10.1107/S1600536812000542

2012-01-01

Abstract:In the title compound, C 16H 16N 2O 6, the dihedral angle between the two pyrrolidine rings is 79.38 (14)°.

What problem does this paper attempt to address?

4-(3,5-Dioxo-10-oxa-4-aza-tricyclo-[5.2.1.0]decan-4-yl)-10-oxa-4-aza-tricyclo-[5.2.1.0]decane-3,5-dione.

Peng-Peng Wang,Qiu-Yue Lin,Fan Zhang

DOI: https://doi.org/10.1107/S1600536812000542

2012-01-01

Abstract:In the title compound, C(16)H(16)N(2)O(6), the dihedral angle between the two pyrrolidine rings is 79.38 (14)°.
Exo-4-[(1H-Benzimidazol-2-yl)methyl]-10-oxa-4-azatricyclo-[5.2.1.0 2,6]decane-3,5-dione

Shikun Li,Fan Zhang,TianXi Lv,Qiuyue Lin

DOI: https://doi.org/10.1107/S1600536811026602

2011-01-01

Abstract:In the title compound, C 16H 15N 3O 3, the dihedral angle between the approximately planar benzimidazolyl group (r.m.s. deviation = 0.010 Å) and the pyrrolidine ring is 78.20 (6)°. The C - C - N bond angle of the bridging CH 2 group is 112.14 (16)°. In the crystal, molecules are linked via N - H⋯N hydrogen bonds, forming infinite chains parallel to [101] and [101̄ ].
exo-4-[(1H-Benzimidazol-2-yl)meth-yl]-10-oxa-4-aza-tricyclo-[5.2.1.0]decane-3,5-dione.

Shi-Kun Li,Fan Zhang,Tianxi Lv,Qiu-Yue Lin

DOI: https://doi.org/10.1107/s1600536811026602

2011-01-01

Abstract:In the title compound, C16H15N3O3, the dihedral angle between the approximately planar benzimidazolyl group (r.m.s. deviation = 0.010 A) and the pyrrolidine ring is 78.20 (6)°. The C—C—N bond angle of the bridging CH2 group is 112.14 (16)°. In the crystal, molecules are linked via N—H⋯N hydrogen bonds, forming infinite chains parallel to [101] and [10\overline{1}].
2,2&#8242;-Dithioditerephthalic acid

Ling Zhang

DOI: https://doi.org/10.1107/S1600536809013622

2009-01-01

Abstract:In the title molecule, C16H10O8S2, the two aromatic rings form a dihedral angle of 87.97 (12)°. In the crystal structure, intermolecular O—H...O hydrogen bonds [O...O = 2.623 (3)–2.639 (3) Å] link the molecules into layers parallel to the ab plane.
(1′S,4′S)-5-(2,5-Dimethylphenyl)-4′-methoxy-6-oxa-3-azaspiro[bicyclo[3.1.0]hexane-2,1′-cyclohexan]-4-one

Jin-Hao Zhao,Jing-Li Cheng,Bing-Rong Xu,Xing-Rui He

DOI: https://doi.org/10.1107/S1600536813005138

2013-01-01

Abstract:In the title compound, C18H23NO3, the cyclohexane ring has a chair conformation. The oxirane plane (OCC) makes a dihedral angle of 76.15 (13)° with that of the pyrrolidine ring to which it is fused. The mean plane of the cyclohexane ring and the benzene ring are almost normal to the pyrrolidine ring, with dihedral angles of 88.47 (8) and 77.85 (8)°, respectively. In the crystal, molecules are linked via pairs of N—H...O hydrogen bonds, forming inversion dimers. These dimers are linked via pairs of C—H...O hydrogen bonds, forming chains along the a-axis direction.
(1′S,4′s)-5-(2,5-dimethylphenyl)-4′-methoxy-6-oxa-3-azaspiro[bicyclo[3.1.0]hexane-2,1′-cyclohexan]-4-one

Xing-Rui He,Bing-Rong Xu,Jing-Li Cheng,Jin-Hao Zhao

DOI: https://doi.org/10.1107/s1600536813005138

2013-01-01

Abstract:In the title compound, C18H23NO3, the cyclohexane ring has a chair conformation. The oxirane plane (OCC) makes a dihedral angle of 76.15 (13)degrees with that of the pyrrolidine ring to which it is fused. The mean plane of the cyclohexane ring and the benzene ring are almost normal to the pyrrolidine ring, with dihedral angles of 88.47 (8) and 77.85 (8)degrees, respectively. In the crystal, molecules are linked via pairs of N-H center dot center dot center dot O hydrogen bonds, forming inversion dimers. These dimers are linked via pairs of C-H center dot center dot center dot O hydrogen bonds, forming chains along the a-axis direction.
7-(Benzyloxy)Spiro[2h-1,3-Benzoxazine-2,1 '-Cyclohexan]-4(3h)-One

Sz Jian,M Lei

DOI: https://doi.org/10.1107/S160053680502845X

2005-01-01

Abstract:In the title compound, C20H21NO3, the dihedral angle between the two benzene rings is 8.79 ( 7)degrees and the cyclohexane ring adopts a chair conformation. The molecules are linked by paired N-H O-... hydrogen bonds into centrosymmetric R-2(2)(8) dimers.
(3ar*,6s*,7s*,7ar*)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

Jian Zhao,Jin-Long Wu

DOI: https://doi.org/10.1107/S1600536810017010

2010-01-01

Abstract:The title compound, C(28)H(26)N(2)O(4), crystallizes as a racemate with four stereogenic centers. In the molecule, the pyrrolidone ring adopts an envelope conformation and the cyclohexene ring has a twisted envelope conformation. In the crystal structure, molecules are linked by weak intermolecular C-H center dot center dot center dot O hydrogen bonds.
(1R,4s,8r,9r,12s,13s,14r,16s,17r,19r)-17-[(ethylsulfanyl)methyl]-9,14-dihydroxy-7,7-dimethyl-2,18-dioxo-3,10-dioxapentacyclo[14.2.1.01,13.04,12.08,12]nonadecan-19-yl Acetate Acetone Solvate

Hao Shi,Hong Xiang Sun

DOI: https://doi.org/10.1107/s1600536808043341

2008-01-01

Abstract:The title compound, C24H32O8S center dot C3H6O, features three six-membered and two five-membered rings. The six-membered rings adopt chair, boat and slightly distorted boat conformations whereas one five-membered ring adopts an approximate envelope conformation and the other a twist conformation. Disorder was modelled for the ethylthio group with the ethyl-C atoms resolved over three positions with occupancies of 0.58 (4), 0.23 (4) and 0.19 (3). In the crystal, an O-H center dot center dot center dot O hydrogen bond links the molecules into chains.
Ethyl (4aR*,7S*,8S*,8aS*)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1H-isochromene-8-carboxylate

Xiu Qing Jiang,Jin-Long Wu

DOI: https://doi.org/10.1107/s1600536810017009

2010-01-01

Abstract:In the title compound, C18H20O4, both the tetrahydropyranone ring and the cyclohexene ring adopt envelope conformations. The crystal packing is stabilized by weak intermolecular C—H⋯O hydrogen bonding.
(1'S,4'S)-5-(2,5-Dimethyl-phen-yl)-4'-meth-oxy-6-oxa-3-aza-spiro-[bicyclo-[3.1.0]hexane-2,1'-cyclo-hexa-n]-4-one.

Xing-Rui He,Bing-Rong Xu,Jing-Li Cheng,Jin-Hao Zhao

DOI: https://doi.org/10.1107/S1600536813005138

2013-01-01

Abstract:In the title compound, C18H23NO3, the cyclo-hexane ring has a chair conformation. The oxirane plane (OCC) makes a dihedral angle of 76.15 (13)° with that of the pyrrolidine ring to which it is fused. The mean plane of the cyclo-hexane ring and the benzene ring are almost normal to the pyrrolidine ring, with dihedral angles of 88.47 (8) and 77.85 (8)°, respectively. In the crystal, mol-ecules are linked via pairs of N-H⋯O hydrogen bonds, forming inversion dimers. These dimers are linked via pairs of C-H⋯O hydrogen bonds, forming chains along the a-axis direction.
(1S*,4aR*,5S*,6S*,8aR*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1H-2,3-benzoxazin-4-one

Yan Wang,Jin-Long Wu

DOI: https://doi.org/10.1107/s1600536809044195

2009-01-01

Abstract:In the title compound, C28H27NO2, the oxazinone ring adopts a twist-boat conformation and the cyclohexene ring has a twisted envelope conformation. The crystal structure is stabilized by weak non-classical intermolecular C—H...O hydrogen bonds.
(1S,3as,4s,7as)-Ethyl 1-Benzyl-2-(4-methoxybenzyl)-6,7-dimethyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1h-isoindole-4-carboxylate Dichloromethane Monosolvate

Benguo Lin,Jin-Long Wu

DOI: https://doi.org/10.1107/s1600536813002560

2013-01-01

Abstract:In the title compound, C(28)H(33)NO(4)·CH(2)Cl(2), the pyrrolidone ring adopts a twisted envelope conformation and the cyclo-hexene has a half-chair conformation. In the crystal, weak C-H⋯O hydrogen bonds link the components into chains along [100].
3-(2,4-Dichloro-phen-yl)-2-oxo-1-oxaspiro-[4.5]dec-3-en-4-yl Acetate.

Jing-Li Cheng

DOI: https://doi.org/10.1107/s1600536809053951

2009-01-01

Abstract:In the title compound, C17H16Cl2O4, the cyclohexyl ring displays a chair conformation [the four C atoms are planar with a mean deviation of 0.001 (2) Å and the two C atoms at the flap positions deviate by 0.625 (2) and −0.680 (2) Å from the plane]. The furan ring is planar with a mean deviation of 0.004 (2) Å and forms a dihedral angle of 46.73 (2)° with the benzene ring.
3,9-Diphenyl-2,4,8,10-tetraoxaspiro[5.5]undecane

Kui Wang,Dong-Ying Yan,Li-Juan Liu,Shan Liu,Jin-Tang Wang

DOI: https://doi.org/10.1107/s160053680602397x

2006-01-01

Abstract:In the molecule of the title compound, C19H20O4, the 1,3-dioxane rings have chair conformations. Intermolecular C—H...O hydrogen bonds link the molecules and may be effective in the stabilization of the crystal structure.
(1S*,4aR*,5S*,6S*,8aR*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexa-hydro-1H-2,3-benzoxazin-4-one.

Yan Wang,Jin-Long Wu

DOI: https://doi.org/10.1107/S1600536809044195

2009-01-01

Abstract:In the title compound, C(28)H(27)NO(2), the oxazinone ring adopts a twist-boat conformation and the cyclo-hexene ring has a twisted envelope conformation. The crystal structure is stabilized by weak non-classical inter-molecular C-H⋯O hydrogen bonds.
Diisopropyl 3-[(E)-2-(3,4-dimethoxy-phen-yl)ethen-yl]-5-oxocyclo-hex-3-ene-1,1-dicarboxyl-ate.

Shifeng Chen,Chen Zhang,Jian-feng Qi

DOI: https://doi.org/10.1107/s160053680901544x

2009-01-01

Abstract:The title compound, C(24)H(30)O(7), displays a trans configuration with respect to the C=C bond. The cyclo-hexenone ring has an envelope conformation; the flap atom (with the isopropoxycarbonyl groups) is displaced by 0.664 (3) Å from the plane of the other five ring atoms and the carbonyl O atom. The dihedral angle between the cyclo-hexenone ring and the benzene ring is 7.85 (9)°. The meta and para meth-oxy O atoms are displaced by 0.003 (7) and 0.031 (4) Å, respectively, from the benzene ring to which they are attached.
3-(4-Acetoxy-phen-yl)-4-oxo-4h-1-benzopyran-5,7-diyl Diacetate.

Huan-Qiu Li,Yin Luo,Dong-Dong Li,Hai-Liang Zhu

DOI: https://doi.org/10.1107/s1600536809043670

2009-01-01

Abstract:In the title mol-ecule, C(21)H(16)O(8), the dihedral angle between the ring systems is 58.5 (1)°. In the crystal, C-H⋯O inter-actions help to establish the packing.
Ethyl (4ar*,7s*,8s*,8as*)-1-Oxo-7-Phenyl-3,4,4a,7,8,8a-Hexahydro-1h-Isochromen E-8-Carboxylate

Xiu Qing Jiang,Jin-Long Wu

DOI: https://doi.org/10.1107/S1600536810017009

2010-01-01

Abstract:In the title compound, C(18)H(20)O(4), both the tetrahydropyran-one ring and the cyclohexene ring adopt envelope conformations. The crystal packing is stabilized by weak intermolecular C-H center dot center dot center dot O hydrogen bonding.
11&#946;,17a&#945;-Dihydroxy-17a&#946;-methyl-d-homoandrosta-1,4-diene-3,17-dione monohydrate

Ya Qiu,Ying Chen,Peng Xia

DOI: https://doi.org/10.1107/S1600536809010770

2009-01-01

Abstract:In the title compound, C21H28O4·H2O, the cyclohexadienone ring is planar (r.m.s. deviation 0.0186 Å), whereas the two cyclohexane rings and the cyclohexanone ring adopt chair conformations. The crystal structure is stabilized by O—H...O and C—H...O hydrogen bonds.

4-(3,5-Dioxo-10-oxa-4-azatricyclo-[5.2.1.0 2,6]decan-4-yl)-10- oxa-4-azatricyclo-[5.2.1.0 2,6]decane-3,5-dione

4-(3,5-Dioxo-10-oxa-4-aza-tricyclo-[5.2.1.0]decan-4-yl)-10-oxa-4-aza-tricyclo-[5.2.1.0]decane-3,5-dione.

Exo-4-[(1H-Benzimidazol-2-yl)methyl]-10-oxa-4-azatricyclo-[5.2.1.0 2,6]decane-3,5-dione

exo-4-[(1H-Benzimidazol-2-yl)meth-yl]-10-oxa-4-aza-tricyclo-[5.2.1.0]decane-3,5-dione.

2,2&#8242;-Dithioditerephthalic acid

(1′S,4′S)-5-(2,5-Dimethylphenyl)-4′-methoxy-6-oxa-3-azaspiro[bicyclo[3.1.0]hexane-2,1′-cyclohexan]-4-one

(1′S,4′s)-5-(2,5-dimethylphenyl)-4′-methoxy-6-oxa-3-azaspiro[bicyclo[3.1.0]hexane-2,1′-cyclohexan]-4-one

7-(Benzyloxy)Spiro[2h-1,3-Benzoxazine-2,1 '-Cyclohexan]-4(3h)-One

(3ar,6s,7s,7ar)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

(1R,4s,8r,9r,12s,13s,14r,16s,17r,19r)-17-[(ethylsulfanyl)methyl]-9,14-dihydroxy-7,7-dimethyl-2,18-dioxo-3,10-dioxapentacyclo[14.2.1.01,13.04,12.08,12]nonadecan-19-yl Acetate Acetone Solvate

Ethyl (4a<i>R</i>,7<i>S</i>,8<i>S</i>,8a<i>S</i>)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1<i>H</i>-isochromene-8-carboxylate

(1'S,4'S)-5-(2,5-Dimethyl-phen-yl)-4'-meth-oxy-6-oxa-3-aza-spiro-[bicyclo-[3.1.0]hexane-2,1'-cyclo-hexa-n]-4-one.

(1<i>S</i>,4a<i>R</i>,5<i>S</i>,6<i>S</i>,8a<i>R</i>*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1<i>H</i>-2,3-benzoxazin-4-one

(1S,3as,4s,7as)-Ethyl 1-Benzyl-2-(4-methoxybenzyl)-6,7-dimethyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1h-isoindole-4-carboxylate Dichloromethane Monosolvate

3-(2,4-Dichloro-phen-yl)-2-oxo-1-oxaspiro-[4.5]dec-3-en-4-yl Acetate.

3,9-Diphenyl-2,4,8,10-tetraoxaspiro[5.5]undecane

(1S,4aR,5S,6S,8aR*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexa-hydro-1H-2,3-benzoxazin-4-one.

Diisopropyl 3-[(E)-2-(3,4-dimethoxy-phen-yl)ethen-yl]-5-oxocyclo-hex-3-ene-1,1-dicarboxyl-ate.

3-(4-Acetoxy-phen-yl)-4-oxo-4h-1-benzopyran-5,7-diyl Diacetate.

Ethyl (4ar,7s,8s,8as)-1-Oxo-7-Phenyl-3,4,4a,7,8,8a-Hexahydro-1h-Isochromen E-8-Carboxylate

11&#946;,17a&#945;-Dihydroxy-17a&#946;-methyl-d-homoandrosta-1,4-diene-3,17-dione monohydrate

4-(3,5-Dioxo-10-oxa-4-azatricyclo-[5.2.1.0 2,6]decan-4-yl)-10- oxa-4-azatricyclo-[5.2.1.0 2,6]decane-3,5-dione

4-(3,5-Dioxo-10-oxa-4-aza-tricyclo-[5.2.1.0]decan-4-yl)-10-oxa-4-aza-tricyclo-[5.2.1.0]decane-3,5-dione.

Exo-4-[(1H-Benzimidazol-2-yl)methyl]-10-oxa-4-azatricyclo-[5.2.1.0 2,6]decane-3,5-dione

exo-4-[(1H-Benzimidazol-2-yl)meth-yl]-10-oxa-4-aza-tricyclo-[5.2.1.0]decane-3,5-dione.

2,2&amp;#8242;-Dithioditerephthalic acid

(1&#8242;S,4&#8242;S)-5-(2,5-Dimethylphenyl)-4&#8242;-methoxy-6-oxa-3-azaspiro[bicyclo[3.1.0]hexane-2,1&#8242;-cyclohexan]-4-one

(1′S,4′s)-5-(2,5-dimethylphenyl)-4′-methoxy-6-oxa-3-azaspiro[bicyclo[3.1.0]hexane-2,1′-cyclohexan]-4-one

7-(Benzyloxy)Spiro[2h-1,3-Benzoxazine-2,1 '-Cyclohexan]-4(3h)-One

(3ar*,6s*,7s*,7ar*)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

(1R,4s,8r,9r,12s,13s,14r,16s,17r,19r)-17-[(ethylsulfanyl)methyl]-9,14-dihydroxy-7,7-dimethyl-2,18-dioxo-3,10-dioxapentacyclo[14.2.1.01,13.04,12.08,12]nonadecan-19-yl Acetate Acetone Solvate

Ethyl (4a<i>R</i>*,7<i>S</i>*,8<i>S</i>*,8a<i>S</i>*)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1<i>H</i>-isochromene-8-carboxylate

(1'S,4'S)-5-(2,5-Dimethyl-phen-yl)-4'-meth-oxy-6-oxa-3-aza-spiro-[bicyclo-[3.1.0]hexane-2,1'-cyclo-hexa-n]-4-one.

(1<i>S</i>*,4a<i>R</i>*,5<i>S</i>*,6<i>S</i>*,8a<i>R</i>*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1<i>H</i>-2,3-benzoxazin-4-one

(1S,3as,4s,7as)-Ethyl 1-Benzyl-2-(4-methoxybenzyl)-6,7-dimethyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1h-isoindole-4-carboxylate Dichloromethane Monosolvate

3-(2,4-Dichloro-phen-yl)-2-oxo-1-oxaspiro-[4.5]dec-3-en-4-yl Acetate.

3,9-Diphenyl-2,4,8,10-tetraoxaspiro[5.5]undecane

(1S*,4aR*,5S*,6S*,8aR*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexa-hydro-1H-2,3-benzoxazin-4-one.

Diisopropyl 3-[(E)-2-(3,4-dimethoxy-phen-yl)ethen-yl]-5-oxocyclo-hex-3-ene-1,1-dicarboxyl-ate.

3-(4-Acetoxy-phen-yl)-4-oxo-4h-1-benzopyran-5,7-diyl Diacetate.

Ethyl (4ar*,7s*,8s*,8as*)-1-Oxo-7-Phenyl-3,4,4a,7,8,8a-Hexahydro-1h-Isochromen E-8-Carboxylate

11&amp;#946;,17a&amp;#945;-Dihydroxy-17a&amp;#946;-methyl-d-homoandrosta-1,4-diene-3,17-dione monohydrate

2,2′-Dithioditerephthalic acid

(1′S,4′S)-5-(2,5-Dimethylphenyl)-4′-methoxy-6-oxa-3-azaspiro[bicyclo[3.1.0]hexane-2,1′-cyclohexan]-4-one

(3ar,6s,7s,7ar)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

Ethyl (4a<i>R</i>,7<i>S</i>,8<i>S</i>,8a<i>S</i>)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1<i>H</i>-isochromene-8-carboxylate

(1<i>S</i>,4a<i>R</i>,5<i>S</i>,6<i>S</i>,8a<i>R</i>*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1<i>H</i>-2,3-benzoxazin-4-one

(1S,4aR,5S,6S,8aR*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexa-hydro-1H-2,3-benzoxazin-4-one.

Ethyl (4ar,7s,8s,8as)-1-Oxo-7-Phenyl-3,4,4a,7,8,8a-Hexahydro-1h-Isochromen E-8-Carboxylate

11β,17aα-Dihydroxy-17aβ-methyl-d-homoandrosta-1,4-diene-3,17-dione monohydrate